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Abstract
Diabetes mellitus is a disease that often causes diabetic nephropathy complications due to persistent hyperglycaemia.
Phaleria macrocarpa (scheff. Boerl) is one of the plants that has been widely used in the treatment of diabetes
mellitus, but its effect on the risk of diabetic nephropathy is still unknown. A dose of 300mg / 200gbb / day is known
as an effective dose that can significantly reduce blood sugar levels in diabetic rat. This study aims to compare the
effect of Phaleria macrocarpa (scheff. Boerl) fruit extracts on urea and creatinine levels as a parameter of kidney
function in hyperglycaemic mouse models. The study was carried out experimentally using the post-test only with
control group design. All rats were induced with 40 mg / 200gbb of Streptozotocin (STZ) to experience
hyperglycaemia. Group I as negative control was given aquades. Group II was given ethanol extract of Phaleria
macrocarpa (scheff. Boerl) with a dose of 300 mg / 200gbw / day. Group III was given Metformin at a dose of 150
mg / 200gbw / day. The research data were statistically analyzed with α <0.05; CI95%. The mean of urea levels in
Group I (79.80 ± 25.09 mg / dl), II (76.00 ± 22.59 mg / dl and III (59.60 ± 6.35 mg / dl). Kruskal-Wallis test results
showed no significant difference in urea levels between treatment groups (p value = 0.273; CI95%). The mean of
creatinine levels in Group I (0.68 ± 0.07 mg / dl), II (0.63 ± 0.14 md / dL) and III (0.98 ± 0.25 mg / dL). One Way
Anova and Post hoc test results showed a significant difference in mean creatinine levels between Groups I and III (p
= 0.014; 95% CI) and II with III ( p value = 0.006; CI95%). the results of this study can be concluded that the extract
of Phaleria macrocarpa (scheff. Boerl) fruit flesh at a dose of 300 mg / 200gbb has better effectiveness than
metformin dose 150 mg / 200gbb in repairing the kidney function of hyperglycaemia rats.
Keywords = Phaleria macrocarpa (scheff. Boerl) extract, Kidney function, Hyperglycemia, Metformin,
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Abstrak
Diabetes melitus merupakan penyakit yang sering menimbulkan komplikasi nefropati diabetika akibat hiperglikemia
yang menetap. Phaleria macrocarpa (scheff. Boerl.) merupakan salah satu tanaman yang telah banyak digunakan
dalam pengobatan diabetes melitus tetapi efek terhadap risiko nefropati diabetika masih belum banyak diketahui.
Dosis 300mg/200gbb/hari diketahui sebagai dosis efektif yang mampu menurunkan kadar gula darah secara
bermakna pada tikus model diabetes. Penelitian ini bertujuan untuk membandingkan pengaruh pemberian ekstrak
daging buah Phaleria macrocarpa (scheff. Boerl.) terhadap kadar ureum dan kreatinin sebagai parameter fungsi
ginjal pada tikus model hiperglikemia. Penelitian dilakukan secara eksperimental desain post test only with control
group. Semua tikus diinduksi dengan 40 mg/200gbb Streptozotocin (STZ) hingga mengalami hiperglikemia.
Kelompok I sebagai kontrol negatif diberi aquades. Kelompok II diberi ekstrak ethanol Phaleria macrocarpa (scheff.
Boerl.) dengan dosis masing-masing 300 mg/200gbb/hari. Kelompok III diberi Metformin dengan dosis 150
mg/200gbb/hari. Data penelitian dianalisis secara statistik dengan α<0,05;IK95%. Rerata kadar ureum pada
Kelompok I (79,80±25,09 mg/dl), II (76,00±22,59mg/dl dan III (59,60±6,35 mg/dl), Hasil uji Kruskal-Wallis
menunjukan tidak perbedaan yang bermakna kadar ureum antar kelompok perlakuan (nilai p=0,273;IK95%). Rerata
kadar kreatinin Kelompok I (0,68±0,07 mg/dl), II (0,63±0,14 md/dL) dan III (0,98±0,25 mg/dL), Hasil uji One Way
Anova dan Pos hoc terdapat perbedaan bermakna rerata kadar kreatinin antara Kelompok I dan III (p=0,014;IK 95%)
dan II dengan III (nilai p=0,006;IK95%), Hasil penelitian ini dapat disimpulkan bahwa ekstrak daging buah Phaleria
macrocarpa (scheff. Boerl.) dosis 300 mg/200gbb memiliki efektivitas yang lebih baik dibandingkan metformin
dosis 150 mg/200gbb dalam memperbaiki fungsi ginjal tikus model hiperglikemia.
Kata kunci = Ekstrak Phaleria macrocarpa, Fungsi Ginjal, Hiperglikemia, Metformin, Streptozotocin.
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INTRODUCTION
Diabetes Mellitus able to increase about a two-
fold risk for a wide range of vascular diseases,
independently from other conventional risk factors.1 In
2012, there were about 1.5 million deaths caused by
diabetes regarding to increasing of cardiovascular risk
and other disease. The amount of death attributable to
hyperglycaemia that occurred under age 70 years old
more in development countries than in a big country.2
One serious disease that is a complication of
diabetes is diabetic nephropathy, due to microvascular
disorders that accompany chronic hyperglycaemia in
diabetes.3 Diabetic nephropathy is also the biggest
cause of morbidity and mortality in diabetic patients.4
Diabetic nephropathy develops in about 30-40% of
diabetic patients.5 The prevalence of diabetic
nephropathy was reported in 29.4% of diabetics in
Thailand, 20.8% in the Philippines and about 2, 0-
39.3% in Indonesia.2
Hyperglycaemia is an important risk factor for the
development of diabetic nephropathy. Persistent
hyperglycaemia can increase ROS production and
interact with deoxyribonucleic acid (DNA) and
proteins causing oxidative stress and cell damage.6,7 In
addition, the pathogenesis of diabetic nephropathy is
also associated with activation of intracellular
signalling molecules such as protein kinase-C (PKC),
and accumulation of advanced glycation end products
(AGE).8
Hyperglycaemia can also activate the release of
nuclear factor-κB as one of the main mediators in the
regulation of various types of pro-inflammatory and
pro-atherosclerotic target genes in vascular smooth
muscle as well as activating macrophages.9,10 Increased
PKC-β2 activity can also trigger endothelial of blood
vessels to produce prostaglandin E2 and thromboxane
A2, substances that alter the permeability and vascular
response to Angiotensin II. In addition, Protein kinase-
C also contributes to the accumulation of
microvascular matrix proteins by inducing
transforming growth factor (TGF) -β, fibronectin, and
type IV collagen in mesangial cells.11 Eventually this
condition will lead to vascular disorders to various
organs, including the kidneys and cause to renal
impairment which characterized with declining of renal
function and rising of serum urea and creatinine
levels.10,12 Therefore, Good hyperglycaemic control can
reduce the risk of renal disease in diabetes patient. The
intensive glucose control can slow Glomerular
Filtration Rate (GFR) loss and possibly progression to
diabetic nephropathy.13
Phaleria macrocarpa (scheff. Boerl.) fruit has
long been used in traditional medicine as an anticancer
drug, allergies, diabetes mellitus drugs, heart disease,
liver, skin, hypertension, stroke, aches, and flu.14
Results of several previous studies indicate that
Extracts Phaleria macrocarpa (scheff. Boerl.) fruit has
a hypoglycaemic effect through inhibition of the
activity of the α-glucosidase enzyme and repairing
pancreatic beta cell damage.15,16 In addition, Phaleria
macrocarpa (scheff. Boerl.) fruit extract can also repair
damaged blood vessels of diabetic mice by increasing
the regeneration ability of blood vessel wall cells.17
inhibiting the expression of growth factors (VEGF and
TGF-β ) in diabetic mouse kidney tissue so it is thought
to have a potential nephroprotective effect.18
Phaleria macrocarpa (scheff. Boerl.) fruit
contains many active compounds which have various
pharmacological effects. The active compounds consist
of flavonoids, phenolics, alkaloids, tannins, saponins,
and terpenoids. Phenolic and flavonoid compounds are
the highest component of compounds found in the
extract of Phaleria macrocarpa (scheff. Boerl.) fruit.14
Some flavonoid compounds that play an important role
in the treatment of diabetes such as Mangiferin,19
Quercetin,20,21and Naringin.20
Both Mangiferin, Quercetin and Naringin have
hypoglycaemic effects. Mangiferin and Quercetin work
through a mechanism of inhibiting the activity of the
enzyme α-glucosidase thereby reducing glucose
absorption in the intestine.19 In addition, Mangiferin
also increases peripheral glucose use by increasing
activity of glucose-6-phosphate dehydrogenase enzyme
and inhibiting gluconeogenesis, while Quercetin can
also decreases haemoglobin A1c (HbA1c) levels in
diabetic rat models without affecting insulin
activity.21,22
Metformin is a biguanide oral anti-diabetes drug
which has mechanism of action through increasing
insulin receptor sensitivity. The American Diabetes
Association (ADA) has established metformin as a
first-line drug in the pharmacological management of
type 2 DM and is the most widely used drug in the
world.23 Metformin also has the effect of reducing
glucose production in the liver and kidneys
(gluconeogenesis) and inhibits glucose absorption in
the intestine. In addition, Metformin also increases the
sensitivity of muscle tissue and adipose to insulin
thereby increasing the use of peripheral blood sugar
and decreasing the glucagon levels in plasma.24 In
other studies, metformin can repair rat kidney cells
induced by gentamicin which is thought to be related to
inhibitory effects on the formation of reactive oxygen
species (ROS) in kidney tissue, decreases lipid
peroxidation products (thiobarbituric acid reactive
substances) in kidney endothelial cells and increase
total plasma antioxidant systems.25
The aims of this study was to compare the
pharmacological effects of Phaleria macrocarpa
(scheff. Boerl.) fruit extracts and metformin on the
kidney function of diabetic rat models which are
reviewed based on plasma urea and creatinine levels. Is
Phaleria macrocarpa (scheff. Boerl.) fruit extract can
repair kidney function of diabetic rats that have the
potential to experience complications of diabetic
nephropathy and whether the effect is better than
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metformin which has been used as one of the standard
medicines for diabetes? In a preliminary study, it was
found that a dose of 300 mg / 200 gbw / day of
Phaleria macrocarpa (scheff. Boerl.) fruit extract could
significantly decrease the blood sugar levels of diabetic
rat models. Therefore, the dose was   used in this study.
METHOD
This is an experimentally research which conducted
with post-test only with control group design. The
research procedures have been approved by the
Medical and Health Research Committee (MHREC)
Faculty of Medicine, Gadjah Mada University. fifteen
of healthy rats,  2-3 month age and body weigh
between about 150 - 200g  were housed in wire cages
at 25-27 °C and were adapted for a week at
Pharmacology laboratory. The rats were divided by
randomize into 3 groups. All rats were induced with 40
mg/200gbw of Streptozotocin (STZ) to experience
hyperglycaemia. Group I as a negative control were
given drinking water. Group II were given the ethanol
extract of Phaleria macrocarpa (scheff. Boerl.) fruit
flesh with doses of 300 mg/200gbw/day orally and
Group III was given Metformin at a dose of 150
mg/200gbw/day orally. On the 22nd day of treatment,
blood specimens were taken for examination of urea
and creatinine levels. The blood sugar was examined
before and after treatment for confirmation of
hyperglycaemia condition.
Materials and Instruments
This research uses ingredients such as 96% ethanol
solvent, 1% Carboxymethyl Cellulose (CMC),
Metformin HCL 500mg (Forbetes 500®),
Streptozotocin (STZ), kit urea FS reagents (Diasys®),
kit creatinine FS reagents (Diasys®) and GOD-PAP
reagents. Meanwhile, instruments used include
centrifuges (Kubota®), water tubes, spectrophotometers
(Optima® Sp 300), micro pipettes (10 μl and 1000 μl),
digital scales 0.00000-100,000g (Dragon® 303) by
Mettler Toledo Groups, Vortex-mixer, Oral sonde 1.5 x
80 mm and evaporator.
Extract Preparation
Phaleria macrocarpa (scheff. Boerl.) fruit flesh was
extracted using maceration techniques within 96%
ethanol. The flesh of Phaleria macrocarpa (scheff.
Boerl.) fruit was washed, small sliced and dried in the
sun but covered with a black cloth to keep the active
ingredients. The dry Phaleria macrocarpa (scheff.
Boerl.) fruit flesh were mashed into powder. Fifty
grams of powder was extracted in 500 mL 96% ethanol
by maceration (72h) Then, using a rotary vacuum
evaporator to vaporize the remaining ethanol 96%
solvent and then the extract is dried in a water-bath at a
temperature of 60-70 oC until it thickens into a paste.26
Phaleria macrocarpa (scheff. Boerl.) fruit were
obtained from Merapi Herbal Farma, Yogyakarta,
Indonesia and identified at Taxonomy Laboratory,
Faculty of Biology, Jenderal Soedirman University.
Examination of Blood Sugar, Urea and Creatinine
Levels
Blood sample was collected from each research animal
by retro-orbital puncture after an 8-12 hours overnight
fast. The collected blood specimens were centrifuged
to obtain serum samples.  The separated serum samples
were analysed for sugar, urea and creatinine. The blood
sugar levels check is carried out using the GOD-PAP
method by using a spectrophotometer at a wavelength
of 546 nm. Urea levels was determined by kit urea FS
reagents, while Creatinine levels was by kit creatinine
FS reagents by using a spectrophotometer at a
wavelength of 546 nm. All these methods were based
on manufacturer’s instructions.27,28
Statistical Analysis
The differences of serum urea levels among
groups of the study were tested with Kruskal-Wallis
test while the differences of serum creatinine levels
among groups of the study were tested with One-Way
Anova test followed by post hoc test (LSD).
RESULT
The fasting blood sugar levels were measured to find
out whether a hyperglycaemic rat models has been
formed in all study groups or not before given the
extract of Phaleria macrocarpa (scheff. Boerl.) fruit
and Metformin. The fasting blood sugar levels were
measured using the GOD-PAP method with a
spectrophotometer at a wavelength of 546 nm. The
measurement results showed that all rats in all of study
groups had normal fasting blood sugar levels before
being induced with Streptozotocin (107.40-116.00mg /
dl) and after being induced, all mice experienced an
increase in blood sugar levels that exceeded normal
fasting blood sugar levels ( healthy), which is more
than 122.3 + 16.28 mg / dl.29 The mean blood sugar
levels in each study group can be seen in table 1.
Therefore, in this study a hyperglycaemia mouse model
can be well formed.






I 5 116,00±2,83 302.80±110.88
II 5 113,40±6,23 344,20±72,11
III 5 114,20±5,76 357,80±41,57
n=sample size
The results of urea levels examination in each
study group showed that the negative control group
(hyperglycaemia models without treatment)
experienced the highest increase in urea levels (79.80 ±
25.09 mg / dL) compared to the other study groups that
were given treatment, both with the extracts of
Phaleria macrocarpa (scheff. Boerl.) fruit and
Metformin. The study group that was given the
treatment of Metformin, had the lowest urea levels
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(59.60 ± 6.35 mg / dL) while the average urea levels in
the Phaleria macrocarpa (scheff. Boerl.) fruit extract
group was 76.00 ± 22.59 mg / dL, as seen in figure 1.
When compared with the normal urea level of healthy
rat (17,1 or between 12.3-24,6 mg / dL), all mice in all
study groups had a urea level of 3.5-4.7 times higher.30
The results of statistical analysis using the Kruskal-
Wallis Test showed that there was not significantly
difference on the serum urea levels among the study
groups (p-value = 0, 273; CI95%)
Figure 1. The serum urea levels of each study group
The results of serum creatinine levels examination
it was found that the lowest creatinine levels were
found in group 2 treated with the extracts of Phaleria
macrocarpa (scheff. Boerl.) fruit (0.63 ± 0.14 mg / dL)
and the highest was found in group 3 treated with
Metformin (0.98 ± 0.25 mg / dL). Group 1 as a
negative control had a mean creatinine level of 0.68 ±
0.07 mg / dL, as showed in figure 2. When compared
with the normal standard mean of Creatinine levels in
healthy mice (0.3 or between 0.2-0.5 mg / dL), serum
creatinine levels increase 2-3 times in all of the Study
Groups and even in group 3 can reach more of 3 times
of healthy rat.30
Figure 2. The serum creatinine levels of each study
group
Statistical analysis using the One-way Anova test
showed that there were significant differences in mean
of serum creatinine levels between study groups (p-
value = 0.012; CI95%). In the post hoc test with LSD,
it was found that there was a significant difference the
average of serum creatinine levels between group I
(negative control) and group III who were given
Metformin treatment (p-value = 0.014; CI95%) and
between group II who were treated with the extracts of
Phaleria macrocarpa fruit with group III (p-value =
0.006; CI95%)
DISCUSION
The hyperglycaemia that occurred in this study
was caused by Streptozotocin which after being given
would selectively accumulate in the β cells of the islets
of Langerhans through the glucose transporter (GLUT
2) and cause a series of damage processes in β cells.
Streptozotocin causes changes in DNA, activates
reactive oxygen species (ROS), forms superoxide
anions in mitochondria and increases xanthine oxidase
activity which inhibits the Krebs cycle and decreases
ATP production. This series of processes resulted in
the death of β cells in the islets of Langerhans, thereby
inhibiting pro-insulin synthesis and ultimately inducing
hyperglycaemia in all experimental animals.31
Persistent High blood sugar levels
(hyperglycaemia) will activate oxidative stress reaction
pathways in cells, including those in the kidney organs.
In general, kidney cells are very susceptible to
extracellular hyperglycaemia because the kidneys have
transporters that do not require insulin. Exposure to
chronic hyperglycaemia in renal glomerular mesangial
cells has been shown to increase GLUT 1 and increase
influx of glucose into cells.32 Changes in the expression
of transporters in glomerular cells and kidney tubules
has a strong contribution to renal cells damage
regarding   increasing of intracellular glucose levels
that activate oxidative stress pathways on the
pathophysiology of kidney dysfunction in diabetes
(diabetic nephropathy).32,33
In this study, impaired kidney function was
demonstrated by elevated serum urea and creatinine
levels exceeding normal levels in healthy rat.
Increasing of urea and creatinine levels on impaired
renal function due to hyperglycaemia were seen in
group I (negative control). In this group, the mean of
serum urea levels could reach 3.5-4.7 times of the
healthy rat urea levels while the serum creatinine levels
could reach 2-3 times. The results of this study, can
support the theory and results of previous studies
which state that hyperglycaemia can cause kidney
damage or known as diabetic nephropathy.
In this study, the potency of nephroprotective
effect of the extracts of Phaleria macrocarpa (scheff.
Boerl.) fruit on hyperglycaemia rat models has been
evaluated and showed that this extract was able to
decrease urea and creatinine levels in experimental
animals. In this study, the potential nephroprotective
effect of Phaleria macrocarpa (scheff. Boerl.) fruit
extracts in hyperglycaemic rat models was evaluated
and showed that this extract was able to decrease serum
urea and creatinine levels in experimental animals. The
results of this study indicated that the active compound
contained in Phaleria macrocarpa (scheff. Boerl.) fruit
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repair kidney cell damage due to hyperglycaemia
caused by damage to β-cells of the islet of the
pancreatic Langerhans.
As it is known that Phaleria macrocarpa (scheff.
Boerl.) fruit extract contains several important active
compounds that have pharmacological effects such as
hypoglycaemia, anti-oxidant and anti-inflammatory
effects.15,19 Flavonoid compounds (Mangiferin,
Quercetin and Naringin) have an important role for the
hypoglycaemia effect of Phaleria macrocarpa (scheff.
Boerl.) fruit extracts through several mechanisms, such
as inhibition of the activity of α-glucosidase enzymes
in the intestine, inhibits gluconeogenesis, increases
sensitivity of insulin receptors in peripheral tissues and
other mechanisms that all of these mechanisms cause a
decrease in blood sugar levels. 19,21
Decreased blood sugar levels in experimental
animals will stop the process of kidney damage that
occurs due to the induction of hyperglycaemia by
reducing oxidative stress reactions in glomerular cells,
tubules and other kidney cells, stopping damage to cell
DNA, repairing the mitochondrial system in producing
ATP and ultimately stimulating regeneration and repair
of kidney cells.
Besides the effects of hypoglycaemia, another
important effect possessed by active compounds in the
extract of Phaleria macrocarpa (scheff. Boerl.) fruit is
the antioxidant effect. Anti-oxidant effect is very
important in the process of controlling complications of
diabetic nephropathy. This is considering that one of
pathogenesis pathway of diabetic nephropathy through
the oxidative stress pathway due to the activation of the
reactive oxygen species (ROS) system by
hyperglycaemic conditions. The oxidative stress
pathway is an important pathway that induces damage
and cell death resulting in impaired organ function.
Therefore, the oxidative stress process is one of the
targets of active compounds which have anti-oxidant
effects.
In this extract, the anti-oxidant effect is mainly
played by alkaloids, saponins and flavonoids
compounds. Among these three compounds, flavonoids
have the highest anti-oxidant effect.20These active
compounds work by increasing the activity of
antioxidant enzymes and decreasing free radicals so as
to prevent further oxidative stress.34
Another effect of the active compound in
Phaleria macrocarpa (scheff. Boerl.) fruit extract is the
anti-apoptotic effect played by benzophenone
glycoside derivatives (similar to the phalerin
compound contained in the leaves of Phaleria
macrocarpa (scheff. Boerl.). Anti-apoptotic effect
occurs through suppression of the activity of Caspase-3
thereby suppressing kidney cell death and increasing
proliferation to repair cell damage that occurs.35All of
these effects, both the effects of hypoglycaemia,
antioxidants and anti-apoptosis, form a protective
effect and repair of kidney cells from damage caused
by hyperglycaemia.
Effect of Metformin on serum urea levels showed
a better effect than the extract group and the control
group. The Metformin group (group III) had the lowest
serum urea levels among the three study groups.
However, on examination of serum creatinine levels,
the group treated with Metformin actually showed a
significant increase in serum creatinine levels
compared to the extract and negative / sick control
groups. In the examination of serum creatinine levels,
the group treated with extract of Phaleria macrocarpa
(scheff. Boerl.) fruit had the lowest serum creatinine
levels. Why does this happen?
In general, Metformin is an antihyperglycemic
drug that works without affecting insulin secretion.
This drug does not cause insulin secretion stimulation
on B cells of Langerhans Islets  to reduce blood sugar
levels but works through several other mechanisms,
such as reducing hepatic and renal gluconeogenesis,
inhibiting glucose absorption in the intestine,
increasing the use of blood sugar by peripheral tissues
and decreasing glucose levels in plasma.24
Other mechanisms of Metformin to prevent
complications of diabetes are through improved
glycogenesis processes, increased sensitivity of insulin
receptor, increased carbonyl compounds, and the
formation of AGEs so as to prevent glucotoxicity and
reduce oxidative stress due to free radical formation.36
Metformin also has an antiapoptotic effect by
suppressing caspase-3 activity, stimulating the
synthesis of Glucagon Like Peptide-1 (GLP-1) and
secretion of endocrine L cells in the intestine that play
a role in regulating cell proliferation. Through this
mechanism, Metformin has the effect of preventing
excessive cell death and is able to stimulate cell
regeneration for the repairing of organ function. 24,36
But why in this study, Metformin did not show
good effectiveness in inhibiting and repairing impaired
kidney function in hyperglycaemic rats? An analysis of
this problem might be explained by the
pharmacokinetic properties of this drug. Metformin is
given orally and will experience absorption in the
intestine. Metformin does not bind to plasma proteins,
is not metabolized in the body and is excreted through
the kidneys. When kidney damage occurs, Metformin
cannot be excreted properly and accumulates in the
blood. Therefore, it can potentially experience
intoxication in the form of over- pharmacodynamic
effects. One of the dangerous effects is the inhibition of
gluconeogenesis which can interfere with lactic acid
metabolism in the liver so that it can cause lactic
acidosis in hyperglycaemic mouse models. This
condition can ultimately increase damage to cells and
organs including the kidneys.24
In this study, the possibility of metformin
intoxication was demonstrated by an increase in
creatinine levels more than 3-fold compared to normal
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levels of creatinine levels in healthy rat. In the
statistical analysis, elevated creatinine levels in the
group treated with Metformin showed significant
differences compared to the extract and control groups.
Therefore, administration of Metformin in
hyperglycaemic conditions that have shown kidney
damage needs to be considered to be discontinued
although further research is still needed in order to find
other scientific facts that support this truth.
The results of this study have shown a potency of
nephroprotective effect on Phaleria macrocarpa
(scheff. Boerl.) fruit extracts. However, the
nephroprotective effect that occurred in this study has
not shown good efficacy. Decreased levels of urea and
creatinine that occur have not been able to reach the
levels equivalent to normal levels of urea and
creatinine in healthy rat. This does not mean that this
extract cannot be used for medicinal purposes.
Research on the extract of Phaleria macrocarpa
(scheff. Boerl.) fruit still needs to be continued with a
different approach and modification. One factor that
has not been revealed is related to the characteristics of
"time-dependent effect" which allows the extract to
work optimally (causing high efficacy) when given in
sufficient time to cause the expected therapeutic effect.
Therefore, what is likely to occur in this study is the
time of administration of the extract which has not
been able to show a true nephroprotective effect so that
it has not been able to reduce urea and creatinine levels
to the maximum. For this reason, further research is
needed with administration of extracts longer and more
variation in dosage.
CONCLUSION
The results of this study can be concluded that the
extract of Phaleria macrocarpa (scheff. Boerl) fruit
flesh at a dose of 300 mg / 200gbb more effective than
metformin dose 150 mg / 200gbb in repairing the
kidney function of hyperglycaemia rats. however, it is
need the further research with a different approach and
modification, especially related with duration of the
extract administration.
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